Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valbenazine in tardive dyskinesia
NCT05859698Phase 4Completed
- Sponsor
- Neurocrine Biosciences
- Start
- May 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valbenazine in tardive dyskinesia (TD), sponsored by Neurocrine Biosciences. Started May 2023; status: completed.
02
Drugs
valbenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT05859698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05859698.